Related Experiment Video
Updated: Apr 28, 2026
07:12
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
6.5K
Intense FDG activity in focal hepatic steatosis
Yali Le1, Yue Chen, Zhanwen Huang
1From the Department of Nuclear Medicine, Affiliated Hospital, Luzhou Medical College, Luzhou, Sichuan, People's Republic of China.
Clinical Nuclear Medicine
|May 31, 2014
Summary
Intense FDG uptake on PET/CT scans can indicate focal hepatic steatosis, not necessarily malignancy. This finding highlights the importance of pathological examination for accurate liver disease diagnosis.
Area of Science:
- Radiology
- Nuclear Medicine
- Pathology
Background:
- Positron Emission Tomography/Computed Tomography (PET/CT) is a crucial imaging modality for evaluating liver lesions.
- Distinguishing between malignant and benign liver conditions is essential for appropriate patient management.
Observation:
- A 38-year-old woman presented with suspected hepatic malignancy, prompting a PET/CT scan.
- The PET/CT revealed significant Fluorodeoxyglucose (FDG) uptake in multiple hypodense liver regions, particularly in the left lobe's lateral segment.
Findings:
- Pathological examination confirmed the presence of focal hepatic steatosis.
- The intense FDG activity observed on PET/CT was attributed to the metabolic changes associated with steatosis.
Implications:
- This case underscores that increased FDG uptake in the liver does not exclusively indicate malignancy.
- Accurate pathological correlation is vital to prevent misdiagnosis of hepatic lesions identified by PET/CT.
- Focal hepatic steatosis should be considered in the differential diagnosis of hypermetabolic liver lesions on PET/CT.
